Dan Loeb Makes It Official: Out of Herbalife Ltd. (HLF) – ValueWalk Premium
27Jan

Dan Loeb Makes It Official: Out of Herbalife Ltd. (HLF)

Friday’s 13G filing by Dan Loeb’s Third Point LLC reveals that the activist investor no longer has a holding in Herbalife Ltd. (NYSE:HLF).

The filing puts the seal on what has been known for a while.
Loeb’s valuation
Dan Loeb took the opposite side from Bill Ackman’s massive $1B short on Herbalife Ltd. (NYSE:HLF). Ackman has been asserting that the multi-level marketing company is nothing but a pyramid scheme, and that its real value is likely zero.

Loeb . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.

Author

The post above is drafted by the collaboration of the ValueWalk Team.

Related Posts

Tuesday Post Market, Hedge Fund, Company And Economic News Update

May

Every afternoon we provide an update on global market levels, economic news, company news and hedge fund news.   Market Levels   US:  Dow: 12932.10 (-0.59%), S&P 500: 1363.72 (-0.43%), NASDAQ: 2946.27... Read More

Annual Ben Graham Conference Ben Graham

Coho Capital: Why This Stock Today Is Like Geico Was For Ben Graham

Aug

Well-respected Coho Capital is up 20.7% net for the first two quarters of the year, coming out ahead of the S&P 500's 18.5% gain. In their second-quarter letter to... Read More

BAML Raises S&P 500 Target To 1,750

Jul

Bank of America Merrill Lynch (BAML) has increased its S&P 500 (INDEXSP:.INX) 2013 end of year target from 1600 to 1750 in light of expected earnings growth for the rest... Read More

Fannie Mae

New Leaked Treasury Memo Excites Fannie Mae Longs

Apr

New leaked Treasury memo about Fannie Mae has created a buzz, but this isn’t the smoking gun that shareholders are looking for Read More

Valeant

Valeant Pharmaceuticals Under Fresh Scrutiny Over Drug Pricing

Oct

Valeant Pharmaceuticals disclosed late Wednesday that it was subpoenaed by U.S. prosecutors seeking information on its pricing programs. In early trading on Thursday, Valeant’s U.S.-listed shares were down 9% at $156.53. Valeant... Read More

Nokia 8

Nokia Lumia 1020 Seems A Very Well Featured Handset: JPMorgan

Jul

Nokia has unveiled its latest Lumia smartphone — the Lumia 1020, which is equipped with a 41-megapixel camera, in its latest bid to catch up with rivals Samsung Electronics Co.,... Read More

Coca-Cola

Coca-Cola Points Out Winters' Overstated Case, Incorrect Calculation

Apr

Coca-Cola is engaged in an aggressive campaign to counter statements made by activist investor David Winters. The firm contacted ValueWalk to counter statements made by Winter, saying Winters has... Read More

Key Takeaways For Borrowers Post Mortgage Rate Spike

Jun

Mortgage rates spiked to their highest levels this week since July 2011, causing frustration among homebuyers and refinancers who were caught by surprise, as noted by Polyana da Costa... Read More

Charlie Munger

Charlie Munger And Li Lu On The Need For Patient Investing

Sep

A couple of years ago, Charlie Munger and Li Lu co-appeared in an interview in one of China's top finance magazines. As is the case with all of Munger's... Read More

Zebra Technologies

Zebra Technologies Corp. (ZBRA) – In-Depth Investment Thesis

May

Article by Dilantha De Silva Investment thesis The 17% price return of Zebra Technologies Corp. (NASDAQ:ZBRA) shares in the last 12 months came on the back of a strong financial performance... Read More

X
Saved Articles
X
TextTExtLInkTextTExtLInk
0